Reference
Huang J, et al. Anaplastic lymphoma kinase tyrosine kinase inhibitors associated gastrointestinal obstruction, perforation, and ulceration: an analysis of the FDA adverse event reporting system database (FAERS) International Journal of Clinical Pharmacy : 7 Jul 2022. Available from: URL: https://doi.org/10.1007/s11096-022-01425-4
Rights and permissions
About this article
Cite this article
ALK TKIs increase risk of GI obstruction and perforation. Reactions Weekly 1915, 6 (2022). https://doi.org/10.1007/s40278-022-19035-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-19035-9